Comera Life Sciences logo — Comera Life Sciences transforms the formulation of biotherap...

Comera Life Sciences

Comera Life Sciences transforms the formulation of biotherapeutics for the ultimate benefit of patients

Founded 2014 United States Woburn, United States 2 employees Post-IPO Equity Total: $4.10M Biotechnology, Health Care +1

General Information

Company Name Comera Life Sciences
Founded Year 2014
Location United States Woburn, United States
Employees 2
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Post-IPO Equity
Social

BounceWatch is an independent company data service, not affiliated with Comera Life Sciences. To contact Comera Life Sciences, visit comeralifesciences.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Comera Life Sciences compare?

A PDF of Comera Life Sciences and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Comera Life Sciences soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Comera Life Sciences

Comera Life Sciences is a formulation innovator in the field of protein therapeutics, striving to transform the formulation of biotherapeutics for the ultimate benefit of patients. The company's proprietary technology offers patented, FDA-friendly excipients catering to a wide range of therapeutic biologics, making life-saving medicines easier to administer, less immunogenic, more stable, and efficient to produce. Through their efforts to enhance therapeutic protein formulations, Comera aims to turn biologic molecules into biobetters, thereby improving the overall patient experience and potentially extending a product’s lifecycle. Founded in 2014 by prolific entrepreneur David Soane, the company is driven by a team of experienced scientists who are committed to advancing their technology. Recent investment of $4.10M in Post-IPO Equity was made on 01 August 2023. Comera Life Sciences operates at the intersection of Biotechnology, Health Care, and Health and Wellness.

Business keywords: Biotherapeutics, Biopharmaceuticals, Formulation Technology, Excipient Development, Drug Delivery Systems, Therapeutic Biologics, Protein Stabilization, Biobetters, Antibody Formulations, Subcutaneous Administration, High Concentration Formulations, Parenteral Biologics, Excipient Technology, Biophysical Characterization, Surfactant Replacements

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Equity $4.10M -
01 Aug 2023
Series A Undisclosed 2
KBI Biopharma, Phoenix Venture Partners
04 Apr 2018

Comera Life Sciences Alternatives & Competitors

View All Alternatives
Comera Life Sciences vs

Advanced Formulation Technologies for Better Biotherapeutics

Series B
18 employees
Biotechnology, Health and Wellness
Comera Life Sciences vs
CovalX
CovalX Switzerland

Protein Interaction Analytics. The accuracy of mass spectrometry for your biologics project.

22 employees
Biotechnology, Hardware
Comera Life Sciences vs
i2o Therapeutics
i2o Therapeutics United States

Boston-based biotech startup developing novel biologic therapies

Series A
13 employees
Biotechnology, Health Care

FAQ About Comera Life Sciences

Comera Life Sciences transforms the formulation of biotherapeutics for the ultimate benefit of patients
Comera Life Sciences was founded in 2014.
Comera Life Sciences is headquartered in Woburn, United States.
Comera Life Sciences operates in Biotechnology, Health Care and Health and Wellness. Its work centres on Biotherapeutics, Biopharmaceuticals, Formulation Technology and Excipient Development.
Comera Life Sciences has approximately 2 employees.
Comera Life Sciences has completed 2 funding rounds, raising a total of $4.10M. The latest funding stage is Post-IPO Equity.
Top alternatives and competitors to Comera Life Sciences include Lindy Biosciences, Inc., CovalX, i2o Therapeutics, Permeon Biologics, Resonant Sensors Incorporated. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Comera Life Sciences and Lindy Biosciences, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Comera Life Sciences, https://bouncewatch.com/company/comera-life-sciences, updated 20 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes